FDA Licenses New Hemophilia Treatment Medical Video by Pharmacy

FDA Licenses New Hemophilia Treatment

Rating: 0.0 out of 0 votes

Comments (0)

You need to have the Flash Player installed and a browser with JavaScript support.

Description The FDA talks about a new treatment for hemophilia FDA recently licensed a new treatment for hemophilia called Xyntha. Xyntha is a genetically engineered version of factor VIII, a protein essential for blood clotting that is decreased or absent in patients with hemophilia A. More at http://www.usrecallnews.com .
Tags and, drug, fda, food, health, hemophilia, treatment